Showing results (2551-2560 of 2,656) with videos related to
Sort By:
Pageof 266
Cancer Immunology Research|October 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology SymposiumChristopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, et al.Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.Circulation|December 28, 2018
Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch SignalingToshiaki Nakano, Shunsuke Katsuki, Mingxian Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Painting blood vessels and atherosclerotic plaques with an adhesive drug depotChristian J Kastrup, Matthias Nahrendorf, Jose Luiz Figueiredo, et al.Research Square|April 16, 2025
Endothelial ActRIIA inhibition protects the cardiac microvasculature in severe viral respiratory infectionPeng Xia, Sujin Lee, Kangsan Roh, et al.Nature Biomedical Engineering|October 6, 2020
Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell nicheMarvin Krohn-Grimberghe, Michael J Mitchell, Maximilian J Schloss, et al.Cancer Cell|April 12, 2017
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory CancersPer Hydbring, Yinan Wang, Anne Fassl, et al.Medicine|October 6, 2023
Sodium and potassium consumption in Jamaica: National estimates and associated factors from the Jamaica Health and Lifestyle Survey 2016-2017Trevor S Ferguson, Novie O M Younger-Coleman, Karen Webster-Kerr, et al.American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 3, 2017
Palliative Care Professional Development for Critical Care Nurses: A Multicenter ProgramWendy G Anderson, Kathleen Puntillo, Jenica Cimino, et al.Cancer Cell|December 14, 2016
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase InhibitorsXiumei Huang, Edward A Motea, Zachary R Moore, et al.Pageof 266